You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ribavirin-Free

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C, Acute Trial in Australia, New Zealand, United Kingdom (Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin)

Recruiting
  • Hepatitis C, Acute
  • Sydney, New South Wales, Australia
  • +10 more
Jun 23, 2021

HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin

Terminated
Has Results
  • HIV Infections
  • Hepatitis C
  • Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
  • +2 more
  • Birmingham, Alabama
  • +15 more
Nov 2, 2021

Protease Inhibitors in Chronic Hepatitis C

Completed
  • Chronic Hepatitis C
    • Graz, Austria
      Department of Internal Medicine, Medical University of Graz
    Jan 11, 2023

    Hepatitis C Virus Trial (Paritaprevir, Ritonavir, Dasabuvir)

    Unknown status
    • Hepatitis C Virus
    • (no location specified)
    Oct 4, 2019

    Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
    • Phoenix, Arizona
    • +47 more
    Jun 27, 2022

    Acute Myelogenous Leukemia Trial in Rochester (Decitabine)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • Rochester, New York
      University of Rochester
    Jul 1, 2022

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in New York (Ribavirin)

    Terminated
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • New York, New York
      Weill Cornell Medicine
    Sep 20, 2021

    Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

    Terminated
    Has Results
    • Hepatitis C
    • Simeprivir (SMV)
    • +2 more
    • Denver, Colorado
      University of Colorado Denver (Leprino Building)
    Aug 16, 2021

    Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

    Not yet recruiting
    • Liver Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 9, 2023

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • ABT-450/r/ABT-267, ABT-333
    • Ribavirin (RBV)
    • (no location specified)
    Jul 8, 2021

    Hepatitis C Trial in United States (Sofosbuvir/Ledipasvir x 12 weeks, Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks)

    Completed
    Has Results
    • Hepatitis C
    • Sofosbuvir/Ledipasvir x 12 weeks
    • Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks
    • Washington, District of Columbia
    • +3 more
    Apr 12, 2019

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 29, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Insulin Resistance Trial in Geneva (Ledipasvir 90 mg/Sofosbuvir 400 mg, Ribavirin)

    Completed
    • Insulin Resistance
    • Geneva, GE, Switzerland
      Division of Gastroenterology and hepatology, University Hospital
    Apr 29, 2019

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 8, 2021

    Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

    Completed
    Has Results
    • Human Papillomavirus (HPV)-Related Malignancies
    • Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
    • Basking Ridge, New Jersey
    • +5 more
    Dec 14, 2022

    HEAD & NECK Cancer Trial in New York (ribavirin)

    Active, not recruiting
    • HEAD & NECK Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 11, 2023

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Long Term Follow up of Chronic HCV Patients Receiving DAAS

    Recruiting
    • Chronic Hepatitis c
      • Sohag, Egypt
        Sohag University Hospital
      Jun 29, 2022

      The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry

      Recruiting
      • Hepatitis C
      • Direct Acting Antivirals
      • Atlanta, Georgia
        The Taskforce for Global Health
      May 6, 2022

      HCV-TARGET- Hepatitis C Therapeutic Registry and Research

      Active, not recruiting
      • Hepatitis C
        • Phoenix, Arizona
        • +59 more
        Oct 5, 2022

        Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV) Trial in Ha Noi (0.9% NaCl physiological

        Recruiting
        • Acute Respiratory Tract Infections
        • +2 more
        • 0.9% NaCl physiological saline
        • LiveSpo Navax
        • Ha Noi, Vietnam
          The Center for Pulmonology and Respiratory Care, Vietnam Nationa
        Jul 4, 2023

        CCHF Trial (Favipiravir, Ribavirin)

        Not yet recruiting
        • CCHF
        • (no location specified)
        Jul 7, 2023